Clinical and molecular epidemiology of methicillin-resistant staphylococcus aureus among patients in an ambulatory hemodialysis center

Infection Control and Hospital Epidemiology

Volumn 32, Issue 9, 2011, Pages 881-888

  Patel, Gopi ^a   Jenkins, Stephen G ^b   Mediavilla, José R ^c   Kreiswirth, Barry N ^c   Radbill, Brian ^a   Salgado, Cassandra D ^d   Calfee, David P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEPHALOSPORIN; VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COHORT ANALYSIS; FEMALE; HEALTH CARE FACILITY; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NOSE SMEAR; PROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT FAILURE; VASCULAR ACCESS;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; AXILLA; BACTERIAL TYPING TECHNIQUES; CARRIER STATE; CATHETERS, INDWELLING; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HUMANS; INCIDENCE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NOSE; PREVALENCE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A;

EID: 80051741255     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/661598     Document Type: Article

References (31)

1. US Renal Data System. USRDS 2010 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, 2010. http://www.usrds.org/2010/pdf/v2_02.pdf Accessed December 9, 2010
2. Tokars JI, Miller ER, Stein G. New national surveillance system for hemodialysis-associated infections: initial results. Am J Infect Control 2002;30(5):288-295
3. Reed S, Friedman J, Engemann J, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005;26(2):175-183
4. Centers for Disease Control and Prevention. Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients: United States, 2005. MMWR Morb Mortal Wkly Rpt 2007; 56(9):197-199
5. Herwaldt LA. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients. J Hosp Infect 1998;40(suppl B):S13-S23
6. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med 1986;315(2):91-96
7. Lu P, Tsai J, Chiu Y, et al. Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant 2008;23(5):1659-1665
8. Hadley A, Karchmer T, Russell G, McBride D, Freedman B. The prevalence of resistant bacterial colonization in chronic hemodialysis patients. Am J Nephrol 2007;27(4):352-359
9. Eguia J, Liu C, Moore M, et al. Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area. Clin Infect Dis 2005;40(11):1617-1624
10. Resí H, Corí A, Dedeí-Ljuboví A, Hukí M, Avdić E, Kukavica N. Prevalence of MRSA infections in patients on hemodialysis. Med Pregl 2007;60(suppl 2):97-100
11. Mountricha A, Platsouka E, Pappas C, et al. S. aureus nasal carriage among hemodialysis (HD) patients. Clin Nephrol 2006; 65(3):229-230
12. Duran N, Ocak S, Eskiocak A. Staphylococcus aureus nasal carriage among the diabetic and non-diabetic haemodialysis patients. Int J Clin Pract 2006;60(10):1204-1209
13. Ghasemian R, Najafi N, Makhlough A, Khademloo M. Frequency of nasal carriage of Staphylococcus aureus and its antimicrobial resistance pattern in patients on hemodialysis. Iran J Kidney Dis 2010;4(3):218-222
14. Lai C, Liao C, Pai M, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients. Clin J Am Soc Nephrol 2011;6(1): 167-174
15. Mermel L, Eells S, Acharya M, et al. Quantitative analysis and molecular fingerprinting of methicillin-resistant Staphylococcus aureus nasal colonization in different patient populations: a prospective, multicenter study. Infect Control Hosp Epidemiol 2010; 31(6):592-597
16. Maree C, Daum R, Boyle-Vavra S, Matayoshi K, Miller L. Community-associated methicillin-resistant Staphylococcus aureus isolates and healthcare-associated infections. Emerg Infect Dis 2007;13:236-242
17. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008;46(6):787-794
18. Jenkins TC, McCollister BD, Sharma R, et al. Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Infect Control Hosp Epidemiol 2009;30(3): 233-241
19. Johnson L, Venugopal A, Pawlak J, Saravolatz L. Emergence of community-associated methicillin-resistant Staphylococcus aureus infection among patients with end-stage renal disease. Infect Control Hosp Epidemiol 2006;27(10):1057-1062
20. Johnson L, Jose J, Yousif F, Pawlak J, Saravolatz L. Prevalence of colonization with community-associated methicillin-resistant Staphylococcus aureus among end-stage renal disease patients and healthcare workers. Infect Control Hosp Epidemiol 2009; 30(1):4-8
21. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001;50(RR-5):1-43
22. Nouwen J, Ott A, Kluytmans-Vandenbergh M, et al. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule." Clin Infect Dis 2004;39(6):806-811
23. Horan T, Andrus M, Dudeck M. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-332
24. Centers for Disease Control and Prevention. National Health- care Safety Network: Device-Associated Module, Dialysis Event. Atlanta, GA: CDC, 2010. http://www.cdc.gov/nhsn/PDFs/pscManual/8pscDialysisEventcurrent.pdf. Accessed April 14, 2011
25. Mathema B, Mediavilla J, Kreiswirth BN. Sequence analysis of the variable number tandem repeat in Staphylococcus aureus protein A gene: spa typing. Methods Mol Biol 2008;431:285-305
26. Shopsin B, Gomez M, Montgomery SO, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999;37(11): 3556-3563
27. Chen L, Mediavilla JR, Oliveira DC, Willey BM, de Lencastre H, Kreiswirth BN. Multiplex real-time PCR for rapid staphy- lococcal cassette chromosome mec typing. J Clin Microbiol 2009; 47(11):3692-3706
28. Strommenger B, Kettlitz C, Weniger T, Harmsen D, Friedrich AW, Witte W. Assignment of Staphylococcus isolates to groups by spa typing, SmaI macrorestriction analysis, and multilocus sequence typing. J Clin Microbiol 2006;44(7):2533-2540
29. Tenover F, Arbeit R, Goering R, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33(9):2233-2239
30. Herwaldt L, Boyken L, Coffman S, Hochstetler L, Flanigan M. Sources of Staphylococcus aureus for patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2003;23(3):237-241
31. Lautenbach E, Nachamkin I, Hu B, et al. Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol 2009;30(4):380-382